WebApr 25, 2024 · Generic name: burosumab [ bur-OH-sue-mab ] Brand name: Crysvita Dosage form: subcutaneous solution (twza 10 mg/mL; twza 20 mg/mL; twza 30 mg/mL) Drug class: Miscellaneous metabolic agents Medically reviewed by Drugs.com on Apr 25, 2024. Written by Cerner Multum. Uses Warnings Before taking Side effects Interactions … WebCrysvita 10mg vial. 1 vial per 14 days: Pediatric: For patients who weigh less than 10kg, 1mg/kg of body weight rounded to the nearest 1 mg, administered every 2 weeks. For patients who weigh more than 10kg, 0.8 mg/kg of body weight rounded to the nearest 10 mg administered every 2 weeks. The minimum starting dose is 10 mg and may be increased ...
NDC 69794-102 Crysvita Injection Subcutaneous - NDCList.com
Web10 mg/mL (NDC# 69794-102-01) 20 mg/mL (NDC# 69794-203-01) 30 mg/mL (NDC# 69794-304-01) CRYSVITA vials must be stored in the original carton until the time of use under … Web0222798 CRYSVITA 10MG INJ SOL 1X1ML 0222799 CRYSVITA 20MG INJ SOL 1X1ML 0222800 CRYSVITA 30MG INJ SOL 1X1ML (dále jen „CRYSVITA“) podanou společností: Kyowa Kirin Holdings B.V. IČ: KVK 34175189 Bloemlaan 2, 2132NP Hoofddorp, Nizozemské království Zastoupena: Swixx Biopharma s.r.o. Hybernská 5, 110 00 Praha 1 red buds colors
CRYSVITA (Ultragenyx Pharmaceutical Inc.): FDA Package Insert
WebMay 13, 2024 · Crysvita must be administered via subcutaneous injection by a healthcare provider. VI. Billing Code/Availability Information HCPCS code: J0584 Injection, burosumab-twza 1 mg; 1 billable unit = 1 mg NDC: Crysvita 10 mg/mL single-dose vial: 69794-0102-xx Crysvita 20 mg/mL single-dose vial: 69794-0203-xx Web• Crysvita 10 mg/mL vial: 1 vial every 14 days • Crysvita 20 mg/mL vial: 1 vial every 14 days • Crysvita 30 mg/mL vial: 6 vials every 14 days B. Max Units (per dose and over time) [HCPCS Unit]: • XLH o 90 billable units every 14 days (pediatrics) o 90 billable units every 28 days (adults) • TIO o 180 billable units every 14 days III. WebThe NDC Packaged Code 69794-102-01 is assigned to a package of 1 ml in 1 vial, single-use of Crysvita, a human prescription drug labeled by Ultragenyx Pharmaceutical Inc.. The product's dosage form is injection and is administered via subcutaneous form.This product is billed per "ML" milliliter and contains an estimated amount of 1 billable ... knee surgery scraping the knee